Cargando…

Complete remission of a reccurrent mesenteric liposarcoma with rare histological features following the administration of trabectedin

The present study describes a rare case of a mesenteric liposarcoma that resulted in a complete remission (CR) following treatment with trabectedin (Yondelis(®)). The patient presented with abdominal pain and fever. An abdominal mass was identified that corresponded to a mixed-type high-grade mesent...

Descripción completa

Detalles Bibliográficos
Autores principales: TSOUKALAS, N., TOLIA, M., LYPAS, G., PANOPOULOS, C., BARBOUNIS, V., KOUMAKIS, G., EFREMIDIS, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3861568/
https://www.ncbi.nlm.nih.gov/pubmed/24348818
http://dx.doi.org/10.3892/ol.2013.1646
_version_ 1782295665380950016
author TSOUKALAS, N.
TOLIA, M.
LYPAS, G.
PANOPOULOS, C.
BARBOUNIS, V.
KOUMAKIS, G.
EFREMIDIS, A.
author_facet TSOUKALAS, N.
TOLIA, M.
LYPAS, G.
PANOPOULOS, C.
BARBOUNIS, V.
KOUMAKIS, G.
EFREMIDIS, A.
author_sort TSOUKALAS, N.
collection PubMed
description The present study describes a rare case of a mesenteric liposarcoma that resulted in a complete remission (CR) following treatment with trabectedin (Yondelis(®)). The patient presented with abdominal pain and fever. An abdominal mass was identified that corresponded to a mixed-type high-grade mesenteric liposarcoma with wide areas of necrosis, areas of dedifferentiation and features of a leiomyosarcoma. Three months after the removal of the first mass, the patient underwent a second laparotomy, followed by treatment with doxorubicin and ifosfamide. Subsequently, the patient was started on therapy with trabectedin and a CR was noted following only four cycles of therapy. The best responses that are reported in the literature for cases of liposarcoma treated with trabectedin are mostly for liposarcomas of the myxoid/round cell type and are mainly partial responses. In the present study, trabectedin was used for the treatment of a mesenteric liposarcoma of mixed morphological features and a CR was achieved.
format Online
Article
Text
id pubmed-3861568
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-38615682013-12-13 Complete remission of a reccurrent mesenteric liposarcoma with rare histological features following the administration of trabectedin TSOUKALAS, N. TOLIA, M. LYPAS, G. PANOPOULOS, C. BARBOUNIS, V. KOUMAKIS, G. EFREMIDIS, A. Oncol Lett Articles The present study describes a rare case of a mesenteric liposarcoma that resulted in a complete remission (CR) following treatment with trabectedin (Yondelis(®)). The patient presented with abdominal pain and fever. An abdominal mass was identified that corresponded to a mixed-type high-grade mesenteric liposarcoma with wide areas of necrosis, areas of dedifferentiation and features of a leiomyosarcoma. Three months after the removal of the first mass, the patient underwent a second laparotomy, followed by treatment with doxorubicin and ifosfamide. Subsequently, the patient was started on therapy with trabectedin and a CR was noted following only four cycles of therapy. The best responses that are reported in the literature for cases of liposarcoma treated with trabectedin are mostly for liposarcomas of the myxoid/round cell type and are mainly partial responses. In the present study, trabectedin was used for the treatment of a mesenteric liposarcoma of mixed morphological features and a CR was achieved. D.A. Spandidos 2014-01 2013-10-29 /pmc/articles/PMC3861568/ /pubmed/24348818 http://dx.doi.org/10.3892/ol.2013.1646 Text en Copyright © 2014, Spandidos Publications http://creativecommons.org/licenses/by/3.0 This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.
spellingShingle Articles
TSOUKALAS, N.
TOLIA, M.
LYPAS, G.
PANOPOULOS, C.
BARBOUNIS, V.
KOUMAKIS, G.
EFREMIDIS, A.
Complete remission of a reccurrent mesenteric liposarcoma with rare histological features following the administration of trabectedin
title Complete remission of a reccurrent mesenteric liposarcoma with rare histological features following the administration of trabectedin
title_full Complete remission of a reccurrent mesenteric liposarcoma with rare histological features following the administration of trabectedin
title_fullStr Complete remission of a reccurrent mesenteric liposarcoma with rare histological features following the administration of trabectedin
title_full_unstemmed Complete remission of a reccurrent mesenteric liposarcoma with rare histological features following the administration of trabectedin
title_short Complete remission of a reccurrent mesenteric liposarcoma with rare histological features following the administration of trabectedin
title_sort complete remission of a reccurrent mesenteric liposarcoma with rare histological features following the administration of trabectedin
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3861568/
https://www.ncbi.nlm.nih.gov/pubmed/24348818
http://dx.doi.org/10.3892/ol.2013.1646
work_keys_str_mv AT tsoukalasn completeremissionofareccurrentmesentericliposarcomawithrarehistologicalfeaturesfollowingtheadministrationoftrabectedin
AT toliam completeremissionofareccurrentmesentericliposarcomawithrarehistologicalfeaturesfollowingtheadministrationoftrabectedin
AT lypasg completeremissionofareccurrentmesentericliposarcomawithrarehistologicalfeaturesfollowingtheadministrationoftrabectedin
AT panopoulosc completeremissionofareccurrentmesentericliposarcomawithrarehistologicalfeaturesfollowingtheadministrationoftrabectedin
AT barbounisv completeremissionofareccurrentmesentericliposarcomawithrarehistologicalfeaturesfollowingtheadministrationoftrabectedin
AT koumakisg completeremissionofareccurrentmesentericliposarcomawithrarehistologicalfeaturesfollowingtheadministrationoftrabectedin
AT efremidisa completeremissionofareccurrentmesentericliposarcomawithrarehistologicalfeaturesfollowingtheadministrationoftrabectedin